EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Distinct Trajectories of Patient-reported Outcome Radiation Dermatitis in Breast Cancer Patients Undergoing Radiotherapy: A Prospective Longitudinal Study

Yanhong Zhou, Xiaomeng Lu, Wenhui Geng, Fengxia Liu, Lei Li, Jiahui Liu

Clinical Breast Cancer · 2026-12 · 26 (12) · 7-12

DOI: 10.1016/j.clbc.2026.10.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Breast Cancer, 2026-12. Verfasst von Yanhong Zhou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: An increasing body of research has underscored the value of patient-centered care, prioritizing patient-reported outcomes and health-related quality of life as essential endpoints in oncological studies. However, the trajectories of patient-reported outcome radiation dermatitis (PRO-RD) in breast cancer patients undergoing radiotherapy remain unclear. MATERIALS AND METHODS: This was a prospective longitudinal study. This study was conducted from September 2024 to February 2025 at a tertiary hospital in Shijiazhuang, China. A total of 163 breast cancer patients who received radiotherapy were recruited. Data were collected through questionnaires, including general demographic information, disease-related characteristics. During radiotherapy, a validated self-reported outcome scale for radiation dermatitis in breast cancer patients was selected for evaluation once a week until the end of radiotherapy, with a total of 5 evaluations. We used the latent class growth model (LCGM) to identify the latent classes of different symptom trajectories, and the Logistic regression to explore the influencing factors of latent classes. RESULTS: A total of 163 patients were included in this study. Two distinct PRO-RD trajectories were identified: a low-level slow-rise group (66.9%, 109/163) and a high-level rapid-rise group (33.1%, 54/163). Multivariate logistic regression identified younger age and advanced tumor stage as independent risk factors for belonging to the high-level rapid-rise trajectory (P < .05). CONCLUSIONS: This study elucidates the heterogeneous trajectory patterns of PRO-RD in breast cancer patients and identifies key influencing factors. Younger age and advanced tumor stage were associated with membership in the high-risk trajectory and should be prioritized for early preventive interventions.

Schlagwörter

Stichwörter der Autor:innen

Latent class growth modelRadiotherapyRisk factorsSkin toxicitySymptom

Autor:innen und Institutionen

  • Department of Radiation Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
  • Department of Nursing, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China. Electronic address: 13932192058@163.com.

Zitieren

APA

Zhou, Y., Lu, X., Geng, W., Liu, F., Li, L., & Liu, J. (2026). Distinct Trajectories of Patient-reported Outcome Radiation Dermatitis in Breast Cancer Patients Undergoing Radiotherapy: A Prospective Longitudinal Study. Clinical Breast Cancer, 26(12), 7-12. https://doi.org/10.1016/j.clbc.2026.10.006

Vancouver

Zhou Y, Lu X, Geng W, Liu F, Li L, Liu J. Distinct Trajectories of Patient-reported Outcome Radiation Dermatitis in Breast Cancer Patients Undergoing Radiotherapy: A Prospective Longitudinal Study. Clinical Breast Cancer. 2026;26(12):7-12. doi:10.1016/j.clbc.2026.10.006

BibTeX
@article{Zhou2026,
  author = {Zhou, Yanhong and Lu, Xiaomeng and Geng, Wenhui and Liu, Fengxia and Li, Lei and Liu, Jiahui},
  title = {Distinct Trajectories of Patient-reported Outcome Radiation Dermatitis in Breast Cancer Patients Undergoing Radiotherapy: A Prospective Longitudinal Study},
  journal = {Clinical Breast Cancer},
  year = {2026},
  volume = {26},
  number = {12},
  pages = {7--12},
  doi = {10.1016/j.clbc.2026.10.006}
}
Kostenlos starten →